Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database

Dimitrios Nasioudis,Spyridon A Mastroyannis,Emily M Ko,Ashley F Haggerty,Lori Cory,Robert L Giuntoli,Sarah H Kim,Mark A Morgan,Nawar A Latif

Gynecologic Oncology（2022）

引用 3|浏览16

暂无评分

摘要

•1 in 3 patients with stage I EOC experience a delay in adjuvant chemotherapy administration following staging surgery.•Delay in adjuvant chemotherapy has a negative impact on overall survival.•Detrimental impact is more pronounced for patients with stage IC or high-grade serous histology.

查看译文

关键词

Ovarian cancer,Stage I,Postoperative chemotherapy,Treatment wait time,Delay

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要